NewAmsterdam Pharma Statements
KH
Data from NewAmsterdam Pharma`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
31 Dec, 2022
Next reporting period:
31 Mar, 2023
Report frequency:
Quarterly
Earnings release date:
06 Nov, 2024
Expected release date:
—
NewAmsterdam Pharma Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
97.5
—
100
—
0
—
—
0
82.23
84.3
13.928
14.3
101.44
4322.7 %
104
-3.939
-71.7 %
-4.04
-10.492
-10.8
—
0
-78.052
-1532.8 %
-80.05
—
0
-78.052
-1532.8 %
-80.05
-0.955
81.768
—
—
100
—
0
—
—
0
—
0
2.294
0
2.294
15.2 %
0
-2.294
-15.2 %
0
-2.487
0
—
0
-4.78
-307.6 %
0
—
0
-4.78
-307.6 %
0
-0.269
17.751
—
—
100
—
0
—
—
0
30.588
0
1.991
0
1.991
477.7 %
0
-1.991
-477.7 %
0
0.818
0
—
0
-1.173
-184.7 %
0
—
0
-1.173
-184.7 %
0
-0.066
17.751
—
—
100
—
0
—
—
0
—
0
0.345
0
0.345
-24.2 %
0
-0.345
24.2 %
0
1.729
0
—
0
1.385
48.9 %
0
—
0
1.385
48.9 %
0
0.078
17.751
—
—
100
—
0
—
—
0
25.032
0
0.455
0
0.455
23.1 %
0
-0.455
-23.1 %
0
0.384
0
1
0
0.93
-46.3 %
0
—
0
0.93
-46.3 %
0
0.052
17.751
—
—
100
—
0
—
—
0
—
0
0.369
0
0.369
—
0
-0.369
—
0
2.099
0
—
0
1.73
—
0
—
0
1.73
—
0
0.097
17.751